What You Should Know: - InStride Health, a leader in outpatient treatment for childhood anxiety and OCD closes oversubscribed $30M Series B funding round led by General Catalyst with participation from existing investors .406 Ventures,
General Catalyst leads funding round joined by .406 Ventures, Valtruis, Mass General Brigham Ventures, and Hopelab Foundation to bolster insurance-based mental health program availability in new marketsBOSTON, MA / ACCESSWIRE / March 27, 2024 / InStride Health, an outpatient provider of specialty pediatric anxiety a.